This blend combines CJC-1295 and Ipamorelin, both of which are studied for their synergistic effects on growth hormone release and potential impacts on body composition and cellular regeneration in laboratory settings.
CJC-1295 (no DAC)/Ipamorelin 5/5 MG
$60.00
CJC-1295 (no DAC) and Ipamorelin Blend is a combination synthetic peptide formulation designed for research purposes involving growth hormone regulation. CJC-1295 (no DAC) is structurally related to growth hormone-releasing hormone (GHRH), while Ipamorelin is a growth hormone secretagogue acting on the ghrelin receptor. This blend has been developed as a stabilized analog combination primarily studied in laboratory settings for its potential synergistic effects on growth hormone secretion, metabolism, and peptide pharmacology. Preclinical studies have investigated this blend in relation to experimental models of endocrine regulation, muscle growth, and metabolic function.
Research involving the CJC-1295 (no DAC) and Ipamorelin Blend commonly explores:
• The combined role in promoting pulsatile release of growth hormone and insulin-like growth factor 1 (IGF-1) in cellular and animal models.
• Possible synergistic effects on anabolic processes, fat metabolism, and tissue recovery in metabolic and endocrine research systems.
• Experimental evaluation of pharmacokinetics, receptor interactions, and prolonged activity of the blend compared to individual peptides.
• Its activity in studies of aging, muscle hypertrophy, and metabolic disorders, where combined peptide mechanisms and stability are key areas of interest.
The CJC-1295 (no DAC) and Ipamorelin Blend is provided as a lyophilized powder for laboratory research use only (RUO). It is not intended for diagnostic, therapeutic, or clinical applications and must not be used in humans or animals.
Product details:
• Synonyms: CJC-1295 without DAC and Ipamorelin combination
• Purity: ≥98%
• CAS Number: Mixture (individual CAS: CJC-1295 no DAC – 863288-34-0; Ipamorelin – 170851-70-4)
• Molecular Formula: Combination of C172H265N47O51 and C38H49N9O5
• Molecular Weight: Approximately 3047.0 Da (CJC-1295 no DAC) and 711.87 Da (Ipamorelin)
• Appearance: White to off-white lyophilized powder
This product is intended exclusively for scientific research and laboratory investigation in compliance with applicable regulatory guidelines.
In stock
Additional information
| Size | CJC-1295 (no dac)/IPA blend: 10 MG (5/5) |
|---|
